Provided by Tiger Trade Technology Pte. Ltd.

AbCellera Biologics

4.59
+0.16003.61%
Post-market: 4.590.00000.00%16:47 EDT
Volume:7.68M
Turnover:35.16M
Market Cap:1.39B
PE:-9.37
High:4.70
Open:4.45
Low:4.43
Close:4.43
52wk High:6.52
52wk Low:1.94
Shares:303.16M
Float Shares:202.75M
Volume Ratio:0.77
T/O Rate:3.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4900
EPS(LYR):-0.4902
ROE:-14.47%
ROA:-9.99%
PB:1.44
PE(LYR):-9.36

Loading ...

Earning Preview: AbCellera Biologics this quarter’s revenue is expected to decrease by 24%, and institutional views are bullish

Earnings Agent
·
May 03

AbCellera Biologics announces annual shareholder meeting notice

Reuters
·
Apr 30

A Look At AbCellera Biologics (ABCL) Valuation After Its Planned ABCL635 Phase 1 Data Update

Simply Wall St.
·
Apr 24

Press Release: AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call

Dow Jones
·
Apr 20

AbCellera updates financial calendar with upcoming quarterly earnings call

Reuters
·
Apr 20

Analysts Offer Insights on Healthcare Companies: AbCellera Biologics (ABCL), Telix Pharmaceuticals (OtherTLPPF) and Johnson & Johnson (JNJ)

TIPRANKS
·
Apr 15

How Investors Are Reacting To AbCellera Biologics (ABCL) After New Jones Trading Coverage Initiation

Simply Wall St.
·
Apr 13

AbCellera Biologics Initiated at Buy by Jones Trading

Dow Jones
·
Apr 10

AbCellera initiated with a Buy at JonesResearch

TIPRANKS
·
Apr 10

AbCellera Biologics (ABCL) Receives a Buy from Truist Financial

TIPRANKS
·
Apr 06

AbCellera schedules first-quarter earnings release, conference call

Reuters
·
Apr 02

3 Penny Stocks With Market Caps Under $19B To Watch

Simply Wall St.
·
Apr 01

A Look At AbCellera Biologics (ABCL) Valuation After Annual Earnings Reveal Higher Revenue And A Narrower Net Loss

Simply Wall St.
·
Mar 10

Major Investor Quietly Ramps Up Stake in AbCellera Biologics

TIPRANKS
·
Mar 03

Stock Track | AbCellera Biologics Soars 5.26% Intraday on Major Shareholder Acquisition

Stock Track
·
Mar 03

Insiders Quietly Double Down on AbCellera Biologics in Bold Buying Spree

TIPRANKS
·
Feb 28

Stock Track | AbCellera Biologics Soars 5.26% in After-Hours on Insider Buying by Major Shareholder and CFO

Stock Track
·
Feb 28

Thermopylae Holdings Ltd. Acquires AbCellera Biologics Common Shares

Reuters
·
Feb 28

AbCellera CFO Andrew Booth Acquires Common Shares

Reuters
·
Feb 28

Abcellera Warns Growing Generative AI Use Raises Cybersecurity, Privacy, and Operational Risks

TIPRANKS
·
Feb 26